Company profile for Open Orphan

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. It has Europe's only 24-bedroom quarantine clinic with onsite virology lab in Queen Mary's Hospital London. hVIVO supports product development for customers developing antivirals, vaccines and resp...
Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. It has Europe's only 24-bedroom quarantine clinic with onsite virology lab in Queen Mary's Hospital London. hVIVO supports product development for customers developing antivirals, vaccines and respiratory therapeutics, all particularly relevant and topical in the environment of heightened awareness in 2020.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Ireland
Address
Address
18 Fitzwilliam Place, Dublin 2, D02 HH29
Telephone
Telephone
+353 1 6440007
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

http://www.pharmafile.com/news/735248/open-orphan-signs-104-million-contract-global-pharma-client

PHARMAFILE
23 Aug 2022
Open Orphan to commence influenza human challenge study
Open Orphan to commence influenza human challenge study

05 Aug 2022

// John Pinching PHARMA TIMES

https://www.pharmatimes.com/news/open_orphan_to_commence_influenza_human_challenge_study_1453010

John Pinching PHARMA TIMES
05 Aug 2022

http://www.pharmafile.com/news/645329/open-orphan-lands-73mln-influenza-human-challenge-study

PHARMAFILE
19 May 2022

http://www.pharmafile.com/news/632901/open-orphan-begin-first-ever-covid-19-challenge-trial

PHARMAFILE
06 May 2022

http://www.pharmafile.com/news/592373/open-orphan-conduct-first-ever-covid-19-human-challenge-trial

PHARMAFILE
22 Oct 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty